Sign In
Get Clay Free →

Suggestions

    Steven Flostrand

    Senior Director - Value, Access and Pricing Execution at Celgene, a Bristol Myers Squibb Company

    Professional Background

    Steven Flostrand is a seasoned leader within the pharmaceutical industry, currently heading the Worldwide Value, Access, and Pricing (VAP) Execution team at Celgene, a subsidiary of Bristol Myers Squibb. His role emphasizes the importance of pricing and reimbursement strategies specifically for critical oncology products, notably Revlimid, Imnovid/Pomalyst, and Empliciti, as well as upcoming CAR T therapies. Steven brings over 20 years of diverse experience in pharmaceutical consultancy and brand management, effectively bridging his extensive knowledge across both European and American markets.

    Steven's professional journey is characterized by a commitment to innovative brand launches and strategic pricing approaches that cater to the complex landscape of healthcare. His insightful contributions to both mature and emerging products have underpinned successful loss-of-exclusivity management, in/out-licensing strategies, and the design of novel product-service offerings that enhance therapeutic value. His current leadership at Celgene solidifies his status as a driving force in pharmaceutical access and market strategy.

    Education and Achievements

    Steven’s academic credentials are impressive. He earned his MBA with a focus on Entrepreneurship and eBusiness from INSEAD, a world-renowned business school known for its global perspective and dedication to leadership development. This educational foundation complements his Bachelor of Commerce degree in Marketing and International Business from the University of British Columbia (UBC), equipping him with essential skills that are pivotal in today’s dynamic business environment. Additionally, he furthered his studies at the Københavns Universitet - University of Copenhagen, further enriching his market insights and international business acumen.

    As a Canadian-British dual national and a long-term resident of Europe, Steven's multicultural background enhances his ability to navigate complex global markets effectively. His fluency in pricing, pricing excellence, market access, and value communication gives him a competitive edge in securing optimal outcomes in pharmaceutical strategies.

    Notable Achievements

    Throughout his dynamic career, Steven has held various influential positions. Before taking the lead at Celgene, he served as the Senior Director of Pricing Excellence and Lifecycle Management, further developing essential pricing strategies and lifecycle management for product success. In previous roles, he was a Principal of Pricing and Market Access at IQVIA, where his strategic insights contributed significantly to the company's market strategies.

    Steven also held several key positions at Creativ-Ceutical and StratX, focusing on robust pricing and market access strategies that ensure pharmaceutical products reach the patients who need them most. Moreover, his experience at Sanofi-Synthelabo USA as a Senior Marketing Manager and in various marketing roles transitions smoothly from product development to customer engagement and satisfaction.

    His early career at Coca-Cola Company and SmithKline Beecham provided him with insights into brand management that continue to influence his current methodologies in marketing excellence, client engagement, and partner management. Steven’s comprehensive approach to business planning, market sizing, valuation, and deal negotiation is pivotal to achieving exemplary outcomes in the pharmaceutical landscape.

    Expertise and Specialties

    Steven has honed his skills in various specialties throughout his career. He excels in Pricing and Market Access (P&MA), where he focuses on elements such as pricing excellence, managed entry agreements, value development, and value communication. Coupled with his marketing expertise, which encompasses product launch and brand management, Steven's career is a testament to the integration of strategic thinking and operational execution.

    Steven Flostrand epitomizes the modern pharmaceutical leader, showcasing an impressive blend of strategic acumen, extensive industry knowledge, and an unyielding commitment to improving patient access to vital therapies. His career journey reflects not only high-level achievements and a dedication to innovation but also an enduring influence on the healthcare landscape.

    Education and Achievements

    Achievements

    Related Questions

    How did Steven Flostrand develop his expertise in pricing and market access within the pharmaceutical industry?
    What innovative strategies has Steven Flostrand implemented in the launch of new pharmaceutical products like CAR T?
    In what ways has Steven Flostrand's education at INSEAD influenced his approach to business leadership and strategy?
    How does Steven Flostrand integrate his experience from both US and European markets into his work at Celgene?
    What are some of the key challenges Steven Flostrand faces as a leader in the Pricing and Access sector at Celgene?
    Steven Flostrand
    Add to my network

    Location

    Lausanne, Vaud, Switzerland